Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • GMP Failures & Pharma Compliance
    • Common GMP Failures
    • GMP Documentation & Records Failures
    • Cleaning & Sanitation Failures in GMP Audits
    • HVAC, Environmental Monitoring & Cross-Contamination Risks
  • Toggle search form

Qualification and Requalification of Working Standards in QC Laboratories

Posted on November 25, 2025November 25, 2025 By digi


Qualification and Requalification of Working Standards in QC Laboratories

Step-by-Step Guide for Qualification and Requalification of Working Standards in QC Laboratories

Effective management of reference standards in QC laboratories is a critical component of pharmaceutical quality control and compliance. Reference standards—particularly working standards—are essential for establishing the accuracy, consistency, and traceability of analytical methods. It is therefore indispensable to implement a structured system for the qualification and requalification of these standards. This tutorial provides a comprehensive, step-by-step guide for pharmaceutical professionals in the US, UK, and EU regions, detailing regulatory-compliant procedures for qualification, requalification, and comparative assessments of working standards within GMP frameworks.

Understanding the Role of Working Standards in QC Laboratories

Working standards serve as intermediate reference materials used routinely in laboratories to perform analytical testing of APIs, excipients, and finished products. Unlike primary reference standards—which may be official pharmacopoeial standards or certified reference materials (CRMs)—working standards are typically derived from qualified primary standards to support daily assay, impurity profiling, dissolution, and related tests.

Proper management of reference standards in QC laboratories ensures integrity and reliability of test results, crucial for batch release decisions, stability testing, and regulatory submissions. Their qualification and requalification processes uphold scientific validity, traceability to primary standards, and compliance with regulatory expectations such as those outlined in FDA 21 CFR Part 211 and EMA EU GMP Volume 4.

In this section, we delineate the foundational concepts and regulatory context that govern the life cycle of working standards and emphasize the necessity of controlled documentation, secure storage, and periodic verification.

Step 1: Selection and Establishment of Primary Reference Standards

The qualification procedure for working standards begins with the appropriate selection of primary reference standards. These can include official pharmacopoeial substances, certified reference materials from accredited organizations, or in-house standards qualified through formal, documented studies.

Also Read:  Soft Skills for GMP Supervisors: Coaching, Feedback and Escalation

Key criteria for selecting primary standards include:

  • Certainty of Purity and Identity: Verified through robust characterization methods such as mass spectrometry, NMR, or spectroscopic techniques.
  • Traceability: Clear documentation linking the standard to its source, batch number, and certificate of analysis (CoA).
  • Stability Information: Data supporting long-term usability and appropriate storage conditions.

Once established, the primary standard acts as the anchor reference for qualifying working standards, ensuring consistency across batches and laboratories. In line with PIC/S PE 009 guidelines, this step includes documented verification procedures and formal approval by quality assurance.

Step 2: Preparation and Initial Qualification of Working Standards

Following the selection of primary reference standards, the working standard is prepared—either by subdividing, blending, or processing the primary standard substance. The preparation must occur under strictly controlled conditions, adhering to defined procedures to prevent contamination or degradation.

Qualification of the working standard involves the following steps:

  • Verification of Identity and Purity: Confirmatory testing against the primary standard using validated analytical methods. Techniques typically include high-performance liquid chromatography (HPLC), gas chromatography (GC), or spectrophotometry.
  • Establishment of Assigned Value: Determination of potency or concentration relative to the primary standard. Statistical analysis of parallel testing replicates is recommended to assure accuracy.
  • Assessment of Physical Attributes: Evaluation of appearance, moisture content, and particle size, if applicable.
  • Documentation: Preparation of a working standard qualification report detailing methods employed, test data, acceptance criteria, and approval signatures from QA and laboratory management.

This formal qualification ensures the working standard’s fitness for purpose. It is imperative that analytical methods used for qualification are validated in accordance with ICH Q2(R1) principles to ensure reliability and repeatability.

Step 3: Establishing Storage and Handling Controls

Proper management of reference standards in QC extends beyond initial qualification to encompass secure storage and handling controls designed to preserve integrity over time. The stability of working standards must be maintained by applying appropriate environmental controls and documented procedures.

Also Read:  QC Laboratory Documentation: Raw Data, Worksheets and Certificates

Essential storage and handling measures include:

  • Dedicated Storage Facilities: Controlled temperature and humidity conditions as indicated by stability data, with monitoring and alarm systems.
  • Restricted Access: Inventory managed by authorized personnel only, with robust tracking via batch records or electronic systems.
  • Proper Packaging: Use of sealed containers, desiccants, or inert atmospheres when necessary to prevent degradation.
  • SOPs for Handling: Standard operating procedures defining minimum handling steps, prevention of cross-contamination, and sample preservation.

Component traceability and chain-of-custody documentation must accompany every movement or use of working standards, in line with GMP expectations.
Regulators expect demonstrated control throughout the standard’s lifecycle and recommend periodic review of storage conditions supported by scientific rationales.

Step 4: Implementing Scheduled Requalification and Comparisons

Regulatory guidance from authorities such as the FDA and EMA stresses that ongoing quality assurance requires scheduled requalification of working standards. This process verifies that the standard retains its assigned value, purity, and identity over time. It also identifies potential degradation or variability resulting from handling or environmental exposure.

The requalification workflow includes:

  • Scheduled Intervals: Requalification typically occurs annually or based on stability data-driven timelines.
  • Analytical Comparisons: Side-by-side testing of retained working standard samples against the primary standard or previously qualified working standard to detect changes.
  • Use of Trending Data: Analysis of assay results over time to evaluate consistency and to preemptively identify the need for replacement.
  • Documentation of Findings: Comprehensive requalification reports are drafted and reviewed by QA, documenting deviations, corrective actions, and approvals.

When requalification reveals out-of-specification results or unacceptable drift, the working standard must be withdrawn and replaced, with full investigation and regulatory notification if required. This procedural step is critical in maintaining compliance with requirements outlined in EU GMP Annex 15 and GMP chapter on quality control.

Also Read:  Granulation SOP Template: Critical Steps and Documentation Points

Step 5: Documentation and Quality Systems Integration

Throughout the lifecycle—from qualification to routine use and requalification—the management of reference standards in QC must be meticulously documented and integrated within a pharmaceutical quality system. This includes incorporation into:

  • SOPs and Work Instructions: Documented procedures that ensure consistent handling, testing, and control of working standards.
  • Inventory and Tracking Systems: Electronic or manual logs capturing batch numbers, location, usage, and status of each working standard.
  • Change Control and Deviation Management: Formal processes addressing modifications to standards, testing methods, or storage conditions, with risk assessment.
  • Quality Risk Management (QRM): Application of ICH Q9 principles to assess impact of variations in standards on product quality and patient safety.
  • Audit and Inspection Readiness: Ensuring all records and processes relating to qualification and requalification are readily accessible and compliant with inspection expectations.

Implementation of electronic records compliant with FDA 21 CFR Part 11 or Annex 11 requirements may enhance efficiency and traceability. Continuous training of laboratory personnel on these procedures is essential to achieving GMP-compliant management.

Conclusion: Best Practices for Managing Working Standard Qualification in Pharmaceutical QC

The proper qualification and requalification of working standards create a foundation for reliable analytical testing and regulatory compliance. A structured, risk-based approach designed to uphold the highest standards of quality, supported by validated methods and robust documentation, ensures sustained accuracy and stability of laboratory reference materials.

Pharmaceutical organizations operating under FDA, EMA, MHRA, PIC/S, and WHO guidance can benefit from harmonizing their systems with internationally recognized GMP principles and ICH Q10 quality management frameworks. The steps outlined above guide the systematic lifecycle management of working standards to maintain confidence in test results used for product release, stability evaluations, and regulatory submissions.

Through continuous oversight, retraining, and process improvement, QC laboratories can maintain rigorous controls aligned with evolving regulatory expectations and inspection best practices.

Reference Standards Tags:comparisons, pharmagmp, qualification, working standards

Post navigation

Previous Post: Inventory and Traceability of Reference Standards: Logs and Labels
Next Post: GMP Management of Reference Standards and Working Standards in QC

Quick Guide

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • International GMP Inspection Standards and Harmonization
    • Global GMP Inspection Frameworks
    • WHO Prequalification and Inspection Systems
    • US FDA GMP Inspection Programs
    • EMA and EU GMP Inspection Practices
    • PIC/S Role in Harmonized Inspections
    • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
  • GMP Blog

Latest Posts

  • GMP-cGMP Regulations & Global Standards
    • FDA cGMP Regulations for Drugs & Biologics
    • cGMP Requirements for Pharmaceutical Manufacturers
    • ICH Q7 and API GMP Expectations
    • Global & ISO-Based GMP Standards
    • GMP for Medical Devices & Combination Products
    • GMP for Pharmacies & Hospital Pharmacy Settings
  • Applied GMP in Pharma Manufacturing & Operations
    • GMP for Pharmaceutical Drug Product Manufacturing
    • GMP for Biotech & Biologics Manufacturing
    • GMP Documentation
    • GMP Compliance
    • GMP for APIs & Bulk Drugs
    • GMP Training
  • Computer System Validation (CSV) & GxP Computerized Systems
    • CSV Fundamentals in Pharma & Biotech
    • FDA CSV Guidance & 21 CFR Part 11 Alignment
    • GAMP 5 & Risk-Based Validation Approaches
    • CSV in Pharmaceutical & GxP Industries (Use-Cases & System Types)
    • CSV Documentation
    • CSV for Regulated Equipment & Embedded Systems
  • Data Integrity & 21 CFR Part 11 Compliance
    • Data Integrity Principles in cGMP Environments
    • FDA Data Integrity Guidance & Expectations
    • 21 CFR Part 11 – Electronic Records & Signatures
    • Data Integrity in GxP Computerized Systems
    • Data Integrity Audits
  • Pharma GMP & Good Manufacturing Practice
    • FDA 483, Warning Letters & GMP Inspections
    • Data Integrity, ALCOA+ & Part 11 / Annex 11
    • Process Validation, CPV & Cleaning Validation
    • Contamination Control & Annex 1
    • PQS / QMS / Deviations / CAPA / OOS–OOT
    • Documentation, Batch Records & GDP
    • Sterility, Microbiology & Utilities
    • CSV, GAMP 5 & Automation
    • Dosage-Form–Specific GMP (Solids, Liquids, Sterile, Topicals)
    • Supply Chain, Warehousing, Cold Chain & GDP
Widget Image
  • Never Assign Batch Release Responsibilities to Non-QA Personnel in GMP

    Never Assign Batch Release Responsibilities… Read more

  • Manufacturing & Batch Control
    • GMP manufacturing process control
    • Batch Manufacturing record requirements
    • Master Batch record template for pharmaceuticals
    • In Process control checks in tablet manufacturing
    • Line clearance procedure before batch start
    • Batch reconciliation in pharmaceutical manufacturing
    • Yield reconciliation GMP guidelines
    • Segregation of different strength products GMP
    • GMP controls for high potency products
    • Cross Contamination prevention in manufacturing
    • Line clearance checklist for production
    • Batch documentation review before qa release
    • Process parameters control limits in pharma
    • Equipment changeover procedure GMP
    • Batch manufacturing deviation handling
    • GMP expectations for batch release
    • In Process sampling plan for tablets
    • Visual inspection of dosage forms GMP requirements
    • In Process checks for filled vials
    • Startup and Shutdown procedure for manufacturing line
    • GMP requirements for blending and mixing operations
    • Process Control strategy in pharmaceutical manufacturing
    • Uniformity of dosage units in process controls
    • GMP checklist for oral solid dosage manufacturing
    • Process Control
    • Batch Documentation
    • Master Batch Records
    • In-Process Controls
    • Line Clearance
    • Yield & Reconciliation
    • Segregation & Mix-Ups
    • High Potency Products
    • Cross Contamination Control
    • Line Clearance
    • Batch Review
    • Process Parameters
    • Equipment Changeover
    • Deviations
    • Batch Release
    • In-Process Sampling
    • Visual Inspection
    • In-Process Checks for Vials
    • Start-Up & Shutdown
    • Blending & Mixing
    • Control Strategy
    • Dosage Uniformity
    • Hold Time Studies
    • OSD GMP Checklist
  • Cleaning & Contamination Control
  • Warehouse & Material Handling
    • Warehouse GMP
    • Material Receipt
    • Sampling
    • Status Labelling
    • Storage Conditions
    • Rejected & Returned
    • Reconciliation
    • Controlled Drugs
    • Dispensing
    • FIFO & FEFO
    • Cold Chain
    • Segregation
    • Pest Control
    • Env Monitoring
    • Palletization
    • Damaged Containers
    • Stock Verification
    • Sampling & Weighing Areas
    • Issue to Production
    • Traceability
    • Printed Materials
    • Intermediates
    • Cleaning & Housekeeping
    • Status Tags
    • Warehouse Audit
  • QC Laboratory & Testing
    • Analytical Method Validation
    • Chromatography Systems
    • Dissolution Testing
    • Assay & CU
    • Impurity Profiling
    • Stability & QC
    • OOS Investigations
    • OOT Trending
    • Sample Management
    • Reference Standards
    • Equipment Calibration
    • Instrument Qualification
    • LIMS & Electronic Data
    • Data Integrity
    • Microbiology QC
    • Sterility & Endotoxin
    • Environmental Monitoring
    • QC Documentation
    • Results Review
    • Method Transfer
    • Forced Degradation
    • Compendial Methods
    • Cleaning Verification
    • QC Deviations & CAPA
    • QC Lab Audits
  • Manufacturing & In-Process Control
    • Batch Manufacturing Records
    • Batch Manufacturing Records
    • Line Clearance
    • In-Process Sampling & Testing
    • Yield & Reconciliation
    • Granulation Controls
    • Blending & Mixing
    • Tablet Compression Controls
    • Capsule Filling Controls
    • Coating Process Controls
    • Sterile & Aseptic Processing
    • Filtration & Sterile Filtration
    • Visual Inspection of Parenteral
    • Packaging & Labelling Controls
    • Rework & Reprocessing
    • Hold Time for Bulk & Intermediates
    • Manufacturing Deviations & CAPA
  • Documentation, Training & QMS
    • SOP & Documentation Control
    • Training & Competency Management
    • Change Control & QMS Lifecycle
    • Internal Audits & Self-Inspection
    • Quality Metrics, Risk & Management Review
  • Production SOPs
  • QC Laboratory SOPs
    • Sample Management
    • Analytical Methods
    • HPLC & Chromatography
    • OOS & OOT
    • Data Integrity
    • Documentation
    • Equipment
  • Warehouse & Materials SOPs
    • Material Receipt
    • Sampling
    • Storage
    • Dispensing
    • Rejected & Returned
    • Cold Chain
    • Stock Control
    • Printed Materials
    • Pest & Housekeeping
  • Cleaning & Sanitization SOPs
  • Equipment & Qualification SOPs
  • Documentation & Data Integrity SOPs
  • Deviation/OOS/CAPA SOPs
    • Deviation Management
    • Root Cause
    • CAPA
    • OOS/OOT
    • Complaints
    • Recall
  • Training & Competency SOPs
    • Training System
    • Role-Based Training
    • OJT
    • Refresher Training
    • Competency
  • QA & QMS Governance SOPs
    • Quality Manual
    • Management Review
    • Internal Audit
    • Risk Management
    • Vendors & Outsourcing
  • About Us
  • Privacy Policy & Disclaimer
  • Contact Us

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme